Safety and efficacy of ticagrelor as single antiplatelet therapy in prevention of thromboembolic complications associated with the Pipeline Embolization Device (PED): multicenter experience.

Mahmoud H MohammadenStephen W EnglishChristopher J StapletonEman M KhedrAhmed ShoybAhmed HegazyAhmed Elbassiouny

Published in: Journal of neurointerventional surgery (2020)

Ticagrelor is a safe and effective SAPT for the prevention of TEE after FD. Large multicenter prospective studies are warranted to validate our findings.

Keyphrases

antiplatelet therapy
acute coronary syndrome
percutaneous coronary intervention
st segment elevation myocardial infarction
st elevation myocardial infarction
coronary artery disease
cross sectional
atrial fibrillation
double blind
risk factors